Warfarin without Therapeutic Monitoring is a Rodenticide, but this Time it Kills the Patient: A Warfarin Toxicity Case Report
Abstract
According to the American Association of Poison Control Centers (AAPCC), 761 single exposures to the pharmaceutical warfarin were reported in 2021, accounting for more than 10 percent of anticoagulant cases. The cost and mortality caused by warfarin toxicity are very high and usually incurable and fatal. The most important action in the field of warfarin toxicity is to prevent its occurrence. To emphasize how warfarin toxicity occurs, a case is introduced in this regard. A 61-year-old man is found unconscious with a seizure on the street and transported to the hospital by Emergency Medical Services (EMS). In the emergency car, he received a diazepam injection for generalized seizures. His vital signs in the postictal state were as follows: blood pressure 82/44 mmHg, pulse rate 91 bpm, and oxygen saturation (SaO2) 93%. His past medical history includes an ischemic stroke and a myocardial infarction 12 years ago. He underwent Mitral valve repair 11 years ago and a mechanical-type Mitral valve replacement 2 years ago. After undergoing mitral valve replacement surgery, he continued taking warfarin and aspirin for 2 years without consulting a cardiologist or undergoing PT and INR tests. As a result, he suffered a massive intracerebral hemorrhage when his INR level rose above 6. It's important to note that he has no history of depression or suicide attempts. After experiencing decreased consciousness and seizures, he was quickly intubated. A brain CT scan revealed extensive evidence of intracerebral hemorrhage, and he was then transferred to the operating room for craniotomy. To manage the bleeding and because Prothrombin complex concentrate (PCC) was not available, the patient received two grams of fibrinogen, two units of Fresh Frozen Plasma (FFP), 10 mg of vitamin K, and one unit of Packed Red Blood Cells. Unfortunately, after a month-long stay in the ICU, the patient passed away as a result of Ventilator-associated pneumonia (VAP) and sepsis.
[2] Lim GBJNRC. Warfarin: From rat poison to clinical use. Nat Rev Cardiol. 2017.
[3] Pirmohamed MJBjocp. Warfarin: almost 60 years old and still causing problems. Br J Clin Pharmacol. 2006; 62(5):509.
[4] Hanley JP. Warfarin reversal. J Clin Pathol. 2004; 57(11):1132-9.
[5] Zareh M, Davis A, Henderson SJWJoEM. Reversal of warfarin-induced hemorrhage in the emergency department. Western J Emerg Med. 2011; 12(4):386.
[6] Luo Y, Ma C, Yu YJBS. Application of fresh frozen plasma transfusion in the management of excessive warfarin-associated anticoagulation. Blood Sci. 2022; 4(2):57-64.
[7] Schaefer JK, Errickson J, Gu X, Alexandris-Souphis T, Ali MA, Haymart B, et al. Assessment of an intervention to reduce aspirin prescribing for patients receiving warfarin for anticoagulation. JAMA Netw Open. 2022; 5(9): e2231973-e.
[8] Hart RG, Tonarelli SB, Pearce LAJS. Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas. Stroke. 2005; 36(7):1588-93.
[9] Wang S, Zou X-L, Wu L-X, Zhou H-F, Xiao L, Yao T, et al. Epidemiology of intracerebral hemorrhage: a systematic review and meta-analysis. Front Neurol. 2022; 13:915813.
[10] Fang MC, Go AS, Chang Y, Hylek EM, Henault LE, Jensvold NG, et al. Death and disability from warfarin-associated intracranial and extracranial hemorrhages. Am J Med. 2007; 120(8):700-5.
[11] Shireman TI, Howard PA, Kresowik TF, Ellerbeck EFJS. Combined anticoagulant–antiplatelet use and major bleeding events in elderly atrial fibrillation patients. Stroke. 2004; 35(10):2362-7.
[12] Johnson CE, Lim WK, Workman BSJJotAGS. People aged over 75 in atrial fibrillation on warfarin: the rate of major hemorrhage and stroke in more than 500 patient‐years of follow‐up. J Am Geriatr Soc. 2005; 53(4):655-9.
[13] Dong M-F, Ma Z-S, Ma S-J, Chai S-D, Tang P-Z, Yao D-K, et al. Anticoagulation therapy with combined low dose aspirin and warfarin following mechanical heart valve replacement. Thromb Res. 2011; 128(5): e91-e4.
[14] Gungorer BJD, Toxicology C. Risk factors associated with warfarin overdose and complications related to warfarin overdose in the emergency department. Drug Chem Toxicol. 2022; 45(4):1732-8.
[15] Abumuaileq RJEPA. Risk of major bleeding in very elderly patients with atrial fibrillation—a continuous dilemma in the real-world clinics. Evid Perspect Angiol. 2019; 7(1): e119.
[16] Chapman N, Huxley R, Anderson C, Bousser M, Chalmers J, Colman S, et al. Effects of a perindopril-based blood pressure–lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the progress trial. Stroke. 2004; 35(1):116-21.
[17] Uygungül E, Ayrik C, Narci H, Erdoğan S, Toker İ, Demir F, et al. Determining risk factors of bleeding in patients on warfarin treatment. Adv Hematol. 2014; 2014(1):369084.
[18] Ahmed NO, Osman B, Abdelhai YM, El-Hadiyah TMHJIjocp. Impact of clinical pharmacist intervention in anticoagulation clinic in Sudan. Int J Clin Pharm. 2017; 39:769-73.
Files | ||
Issue | Article in Press | |
Section | Case Report(s) | |
Keywords | ||
Warfarin toxicity Aspirin Intracerebral hemorrhage Therapeutic monitoring |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |